|
Volumn 46, Issue 3, 2005, Pages 350-352
|
The CARDS study: Primary prevention of cardiovascular disease with atorvastatin in diabetic patients: Commentary;CARDS-Studie: Kardiovaskuläre primärprävention bei diabetikern mit atorvastatin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
CARDIOVASCULAR DISEASE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
DRUG EFFECT;
DRUG EFFICACY;
HUMAN;
MAJOR CLINICAL STUDY;
NOTE;
PROPHYLAXIS;
TREATMENT OUTCOME;
ANTICHOLESTEREMIC AGENTS;
CEREBROVASCULAR ACCIDENT;
CORONARY DISEASE;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
HEPTANOIC ACIDS;
HUMANS;
MULTICENTER STUDIES;
PYRROLES;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 17444376020
PISSN: 00209554
EISSN: None
Source Type: Journal
DOI: 10.1007/s00108-004-1340-2 Document Type: Note |
Times cited : (1)
|
References (0)
|